Akoya Biosciences
Akoya Biosciences: Providing global spatial biology solutions for precise immuno-oncology therapies.
Founded
2015Akoya Biosciences: Providing global spatial biology solutions for precise immuno-oncology therapies.
Founded in California, Akoya Biosciences, Inc. is dedicated to providing comprehensive spatial biology solutions. The company's core mission is to advance the field of spatial biology to enable the development of precise therapies, particularly in immuno-oncology and drug development. Akoya offers end-to-end solutions for high-parameter tissue analysis, supporting research from discovery through clinical and translational phases. Their market focus spans globally, serving researchers and clinicians aiming to unlock complex biological insights from tissue samples.
Notable affiliates of Akoya Biosciences include partnerships with organizations like NeraCare, enhancing personalized therapy capabilities. Key achievements include the establishment of an Operations and Manufacturing Center of Excellence in Marlborough, which underscores their commitment to innovation and quality. Akoya's impact is significant in the realm of spatial biology, driving forward the precision medicine frontier and enabling breakthroughs in immuno-oncology and other critical therapeutic areas.
Companies similar to Akoya Biosciences include NanoString Technologies, Rebus Biosystems, RareCyte and Aquyre Biosciences.
Akoya Biosciences was founded in 2015.
Akoya Biosciences' headquarters is located in Marlborough, MA, US.
Akoya Biosciences' most recent funding round was for $43.5M (USD) in June 2023.
As of Jun 7, 2023, Akoya Biosciences has disclosed funding of $127M (USD). Undisclosed round amounts are excluded.
Akoya Biosciences has 369 employees as of Feb 6, 2024.
Aquyre Biosciences
lltech.co
